Volker Wagner

Volker Wagner

Company: Bayer

Job title: Head of Clinical Development Radiopharmaceutical


Logical Combination Therapies for Targeted Alpha Therapies 11:30 am

Targeted alpha therapies induce (clustered) DNA double-strand breaks leading to cell death Combination with inhibitors of DNA damage response may increase efficacyPotential for immune system activationRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.